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AbsTRACT
Objective The aim of this review was to investigate 
whether e- cigarette use compared with non- use in young 
non- smokers is associated with subsequent cigarette 
smoking.
Data sources PubMed, Embase, Web of Science, 
Wiley Cochrane Library databases, and the 2018 Society 
for Research on Nicotine and Tobacco and Society for 
Behavioural Medicine conference abstracts.
study selection All studies of young people (up to 
age 30 years) with a measure of e- cigarette use prior to 
smoking and an outcome measure of smoking where an 
OR could be calculated were included (excluding reviews 
and animal studies).
Data extraction Independent extraction was 
completed by multiple authors using a preprepared 
extraction form.
Data synthesis Of 9199 results, 17 studies were 
included in the meta- analysis. There was strong evidence 
for an association between e- cigarette use among non- 
smokers and later smoking (OR: 4.59, 95% CI: 3.60 to 
5.85) when the results were meta- analysed in a random- 
effects model. However, there was high heterogeneity 
(I2=88%).
Conclusions Although the association between e- 
cigarette use among non- smokers and subsequent 
smoking appears strong, the available evidence is limited 
by the reliance on self- report measures of smoking 
history without biochemical verification. None of the 
studies included negative controls which would provide 
stronger evidence for whether the association may be 
causal. Much of the evidence also failed to consider 
the nicotine content of e- liquids used by non- smokers 
meaning it is difficult to make conclusions about whether 
nicotine is the mechanism driving this association.
InTRODuCTIOn
Existing evidence suggests that electronic cigarette 
(e- cigarette) use is less harmful than smoking1 and is 
an effective smoking cessation aid2; however, there 
are concerns that e- cigarettes may act as a gateway 
to smoking cigarettes among young people. If this 
is correct, rather than seeing a decline in smoking 
rates we may see smoking rates remaining stable 
or increasing due to a new generation of smokers 
for whom e- cigarettes have acted as a route into 
smoking. This hypothesis (sometimes referred to 
as the ‘gateway hypothesis’ or ‘catalyst model’) has 
been widely debated among researchers and public 
health officials. Some argue that a common liability 
better explains the association between vaping and 
later smoking, whereby the same genetic or envi-
ronmental factors that increase the likelihood of 
someone vaping also increase the likelihood of 
someone smoking.3 As many people use e- ciga-
rettes to help them stop smoking, it would also be 
logical to assume the opposite direction of causality 
with smoking causing people to vape.4 The lack of 
consensus on the issue demonstrates the need for 
the current evidence to be synthesised.
One systematic review and meta- analysis of the 
association between baseline e- cigarette use and 
later smoking concluded that e- cigarette use was 
associated with an increased likelihood of smoking 
at the follow- up.5 Although this meta- analysis is 
relatively recent, this is a fast- moving field with 
a substantial number of relevant studies having 
been published since 2017. Given the topic is of 
great interest to researchers and policy- makers, an 
updated meta- analysis is necessary. Moreover, in 
the previous meta- analysis,5 moderate heteroge-
neity was observed between the study results. Some 
potential sources of heterogeneity could include 
the age range of the participants in the studies 
and the risk of bias among the studies. Soneji and 
colleagues5 addressed this by stratifying by average 
age, finding that there was greater heterogeneity 
between studies of adolescents (under the age of 
18 years) compared with studies of young adults. 
However, they did not stratify by the risk of bias. 
This is important because the preconceptions of 
study authors may also influence how studies are 
designed and conducted, and this may be reflected 
in a study’s conclusions. For example, two studies 
in the Soneji and colleagues5 meta- analysis drew 
diverging conclusions, despite the pooled ORs not 
differing substantially from each other. Leventhal 
and colleagues6 concluded that there was insuffi-
cient evidence to support the gateway hypothesis, 
whereas Miech and colleagues7 concluded that 
there was a one- way bridge from e- cigarette use to 
smoking, despite both studies having similar results.
In this systematic review and meta- analysis, 
we updated and extended previous reviews in 
which e- cigarette use and later smoking have 
been explored while looking at a broad range of 
evidence. Our aim was to investigate whether e- cig-
arette use, compared with non- use, in young non- 
smokers is associated with subsequent cigarette use 
by combining evidence from studies investigating 
e- cigarette use and subsequent smoking where an 
OR could be calculated. Additionally, we aimed to 
use stratification to explore sources of heterogeneity 
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and biases in conclusions regarding the gateway hypothesis. From 
our knowledge of the evidence base and considering this is a fast- 
moving area of research, we expected to identify a substantial 
number of studies that have been published since the review by 
Soneji and colleagues.5
MeThODs
The protocol for this systematic review and meta- analysis 
was published online prior to initiating the search and can be 
found on the Open Science Framework (https:// osf. io/ 3gc2y/). 
Preferred Reporting Items for Systematic review and Meta- 
Analysis (PRISMA) and MOOSE guidelines were followed 
(where applicable).
eligibility criteria
We included randomised controlled trials, longitudinal studies, 
cross- sectional studies and case–control studies. Only studies 
investigating young people aged up to the age of 30 years old 
(inclusive) were included. Studies had to have a baseline or retro-
spective measure of e- cigarette use (including but not limited to 
ever, occasional, heavy, recent, regular or frequent use) prior to 
initiating smoking and a measure of cigarette smoking (including 
but not limited to ever, occasional, heavy, recent, regular, 
frequent or escalated smoking) as an outcome. Studies had to 
include a comparison group (ie, group which the exposed group 
is compared with), which could include young people who were 
never, trial or not recent e- cigarette users or smokers, dependent 
on the study. Review articles and animal studies were excluded.
Information sources
Our search strategy was a replication and extension of a strategy 
used in a similar review.5 We conducted an electronic search of 
the databases PubMed, Embase, Web of Science, Wiley Cochrane 
Library, Society for Research on Nicotine and Tobacco, and the 
Society for Behavioural Medicine. Due to member- restricted 
access, we were unable to search the National Institutes of 
Health (NIH) Tobacco Regulatory Science Conference abstracts 
as stated in our preregistered protocol. We compared the list of 
studies to be included with those included in previous similar 
reviews to ensure the search strategy had not omitted any rele-
vant studies. Studies written in languages other than English 
were translated by colleagues and using Google translate where 
translations were not already available. The search strategy was 
conducted up to 24 November 2018. E- cigarettes are a relatively 
new product on the consumer market; therefore, no date restric-
tions were placed on the search strategy.
search strategy
Studies were initially selected for screening using the following 
search terms within the titles, abstracts or keywords: Cigar* OR 
Tobacco OR Smok* AND Electronic Cigarette* OR E- Cig* OR 
Electronic Nicotine Delivery System* OR Vape OR Vaping OR 
Alternative Nicotine Delivery System*. Boolean operators and 
truncations differed depending on the database. Relevant MeSH 
terms were included when searching the PubMed database. 
An example search can be found in the online supplementary 
material.
study selection and data collection process
Study selection and data extraction took place over three stages. 
Stage 1 consisted of title and abstract screening; stage 2 consisted 
of a full- text screening; stage 3 consisted of data extraction from 
selected studies. A full list of extracted data is included in the 
online supplementary material. Titles, abstracts and full- text 
articles were double screened and then double extracted by three 
reviewers (JK, [100%], SS [50%] and SP [50%]). Discrepancies 
were resolved by a third reviewer where necessary. Covidence ( 
www. covidence. org), an online systematic review tool that is in 
partnership with Cochrane, was used to streamline and docu-
ment this process.
When insufficient information was available to determine 
eligibility, we contacted study authors. Where insufficient infor-
mation was provided or obtained, the text was excluded from 
the review.
Risk of bias assessment
The risk of bias was assessed using the Newcastle- Ottawa Scale 
(NOS). The selection, comparability and outcome domains 
of the tool were used to assess the risk of bias in all full texts 
included in the review. The studies were rated as good, fair or 
poor quality based on the star system of the tool (maximum of 9 
stars, see online supplementary material for more information). 
Quality/risk was double assessed by the review team. Studies 
were not excluded based on the risk of bias.
Risk of bias across studies was assessed using the symmetry 
and 95% confidence region of a funnel plot.8 Asymmetry and 
>5% of points lying above the 95% confidence region may indi-
cate some bias across studies.
Causality assessment
Using Bradford- Hill criteria, we selected four criteria that were 
relevant to the studies of interest to indicate the strength of 
evidence of a possible causal relationship between our expo-
sure and outcome (see the online supplementary material for 
more details). These were: strength of association, specificity, 
temporality and dose responsivity. These criteria are particularly 
relevant to studies assessing whether e- cigarettes may act as a 
gateway to smoking.3
summary measures
Effect estimates were reported as ORs (and converted where 
necessary). ORs of the association between e- cigarette use and 
later cigarette use were combined using a random- effects model. 
All unadjusted ORs were calculated using observed data points 
that were obtained from the original study or directly from the 
author if insufficient information was provided in the original 
study. Calculated effect sizes were double checked by the review 
team.
Adjusted ORs were reported as they were in the original study 
and adjusted risk ratios were converted to ORs using a modi-
fied version of a formula published in the Cochrane Handbook 
(Section 12.5.4.4)8: OR = (−RR+RR×ACR) / (RR×ACR−1), 
where OR=odds ratio; RR=risk ratio; ACR=assumed control 
risk (calculated on a per study basis as the risk of later smoking 
among controls).
synthesis and results
In a random- effects model, we calculated the pooled ORs from 
unadjusted and adjusted ORs for ever cigarette use at follow- up 
among never smokers at baseline, in ever compared with never 
e- cigarette users at baseline. Where multiple exposure or 
outcome measures were included in the original study, this esti-
mate was used in the main analysis. If ever use of e- cigarettes 
was not reported, then the main effect reported in the study was 
included in our main analyses.
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Figure 1 Study selection flow diagram.
Where possible (ie, where more than one study was available), 
we also analysed the results in a series of subgroups—we pooled 
odds for: (i) ever versus never e- cigarette use at baseline and 
ever versus never smoking at follow- up; (ii) ever versus never 
e- cigarette use at baseline and current (past 30 days) versus non- 
current use of cigarettes at follow- up, and (iii) current versus 
non- current e- cigarette use at baseline and ever versus never 
smoking at follow- up. In retrospective studies, measures of e- cig-
arette use prior to smoking were treated as baseline and smoking 
status at the time of the study was treated as the follow- up. We 
aimed to pool the results of regular (at least monthly for >6 
months) cigarette use at follow- up among never smokers at base-
line, in regular compared with non- regular e- cigarette users at 
baseline; however, insufficient data were available to do so.
Heterogeneity of study effect estimates can be indicated by 
an I2 statistic. Sources of heterogeneity were explored through 
subgroup analysis. All analyses were conducted using Stata SE 
V.15.1 and Review Manager V.5.
Patient and public involvement
This research was done without public involvement. The public 
was not invited to partake in the conception or design of the 
study, or the interpretation of the results. The public was not 
invited to contribute to the writing or editing of this document 
for readability or accuracy. The results of this meta- analysis will 
be disseminated to the public as widely as possible.
ResulTs
study selection
Figure 1 shows the PRISMA study selection flowchart. A total 
of 15 519 studies were selected for title and abstract screening, 
9199 remained after exclusion of duplicates. After title and 
abstract screening, 133 studies were selected for full- text 
screening. Of these, 24 studies were initially selected for inclu-
sion; however, 7 studies were not included in the meta- analysis 
because the data overlapped with other included studies. Where 
data overlapped, the most relevant study was selected based on 
aims (ie, studies where the primary aim addressed the question 
of interest were selected above those which addressed the ques-
tion in secondary analysis) and sample size (ie, larger sample 
sizes were included where both studies were relevant). In the 
meta- analysis, 16 studies were included in the main pooled 
unadjusted analysis and 17 studies were included in the pooled 
adjusted analysis. One study was excluded from the unadjusted 
analysis due to insufficient raw data availability but had adjusted 
results available.
study characteristics
Details of the study characteristics are shown in the online 
supplementary table S1. The majority of the studies included 
were longitudinal and one was cross- sectional in which partic-
ipants were asked questions regarding their product use retro-
spectively. Total study sizes varied considerably, ranging from 
347 to 39 718 and the number of participants included in the 
final analyses were often substantially smaller. Participants were 
mostly under the age of 18 years and many of the studies were 
school- based. Where the number of men and women in the 
study were reported, around 50% of participants were men in 
most cases. However, only 33% were men in one study.9 The 
majority of the studies (10) were conducted in the USA, 3 studies 
took place in the UK, 1 was based in Canada, 1 in Mexico, 1 in 
Germany and 1 in the Netherlands. Follow- up periods ranged 
from 4 to 24 months.
In terms of observed exposures, most studies explored ever 
e- cigarette use with never e- cigarette users as a comparator. 
Two studies looked at current users with not current users as 
the comparator7 10 and two looked at both current and ever 
use.11 12 Only one study considered the amount of exposure to 
nicotine,13 and one study looked at the frequency of e- cigarette 
use.14 In one study that took nicotine use into account,13 two 
separate analyses were conducted for: (1) ever use of nicotine 
containing e- cigarettes (OR: 11.90, 95% CI: 3.36 to 42.11); 
and (2) ever use of non- nicotine containing e- cigarettes (OR: 
5.36, 95% CI: 2.73 to 10.52). However, the analysis groups 
were not mutually exclusive (ie, an individual would have been 
in both analysis groups if they had tried both nicotine containing 
and nicotine free e- cigarettes). No analysis was reported using 
subgroups of exclusive nicotine or nicotine- free use. The one 
study which addressed the frequency of e- cigarette use14 found 
that those who had used e- cigarettes at varying frequencies from 
one time or two times (OR: 2.88, 95% CI: 1.96 to 4.22) to 
weekly/daily (OR: 4.09, 95% CI: 2.43 to 6.88) were more likely 
than those who had not used e- cigarettes to have smoked at least 
once at follow- up.
Most of the included studies used ever smoking as an outcome. 
One study explored experimentation with smoking, as well as 
frequent and infrequent smoking,15 and three looked at recent/
current smoking at follow- up.6 11 12
Covariates included in the analyses varied greatly between 
studies. One study only adjusted for four covariates,16 whereas 
another adjusted for over 20 covariates.17 All studies adjusted for 
sex and most adjusted for age and race/ethnicity. Other frequently 
included covariates were peer smoking, sensation seeking (and 
related factors), and drug and alcohol use. No studies adjusted 
for nicotine exposure via e- cigarettes (ie, e- liquid content and/or 
frequency of nicotine exposure).
Quality/risk of bias within studies and causality
The quality of studies (or inversely, risk of bias) was good in 
most cases when rated using the NOS (online supplementary 
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Table 1 Individual results of studies included in the meta- analysis
Initiated cigarette smoking (n) Odds of initiating smoking
study e- cigarette users never/not current e- cigarette users
unadjusted OR
(95% CI) Adjusted OR (95% CI)
Auf et al19 * * * 3.7 (3.1 to 4.5)
Barrington- Trimis et al15 184/857 280/4171 3.80 (3.10 to 4.66) 4.57 (3.56 to 5.87)
Best et al16 74/183 249/1942 4.62 (3.34 to 6.38) 2.42 (1.63 to 3.60)
Conner et al30 118/343 124/1383 5.32 (3.99 to 7.11) 4.06 (2.94 to 5.60)
East et al38 11/21 74/902 12.31 (5.06 to 29.94) 10.57 (3.33 to 33.50)
Hammond et al10 136/487 1313/16 831 4.58 (3.73 to 5.63) 2.12 (1.68 to 2.66)
Leventhal et al6 19/222 71/2308 2.95 (1.74 to 4.99) 1.75 (1.10 to 2.77)
Loukas et al9 114/568 168/1190 2.72 (2.10 to 3.53) 1.36 (1.01 to 1.83)
Lozano et al18 86/216 950/4479 2.46 (1.85 to 3.26) 1.60 (1.31 to 1.97)†
Miech et al7 4/13 14/213 6.32 (1.73 to 23.10) 6.58 (2.04 to 57.88)†
Morgenstern, et al17 93/312 175/1867 4.11 (3.08 to 5.48) 2.50 (1.82 to 3.54)†
Primack et al21 6/16 65/678 5.66 (1.99 to 16.07) 8.3 (1.2 to 58.6)
Primack et al20 6/16 81/889 6.06 (2.15 to 17.10) 6.82 (1.65 to 28.25)
Spindle et al11 45/153 230/2163 3.50 (2.41 to 5.09) 3.37 (1.91 to 5.94)
Treur et al13 432/740 235/2049 10.83 (8.87 to 13.22) 11.9 (3.36 to 42.11)
Watkins et al12 81/425 387/9923 5.80 (4.46 to 7.54) 2.53 (1.80 to 3.56)
Wills et al14 42/215 50/926 4.25 (2.74 to 6.61) 2.87 (2.03 to 4.05)
Overall 1,451/4787 4340/52 727 4.59 (3.60 to 5.85) 2.92 (2.30 to 3.71)
*Raw data were not available or insufficient information was provided to calculate an accurate unadjusted OR.
†Estimates were provided as risk ratios and converted to ORs.
Figure 2 Forest plot for the unadjusted association between e- 
cigarette use and subsequent smoking.
Figure 3 Forest plot for the adjusted association between e- cigarette 
use and subsequent smoking.
table S2). One study was rated as fair quality,18 and three were 
rated as poor quality.13 19 20 Of the four Bradford- Hill criteria 
for causality deemed relevant to this research, the majority (11 
studies) met three criteria (usually strength of evidence, tempo-
rality and specificity), 4 studies only met two criteria6 9 10 19 and 
2 met four criteria.13 14
Results of individual studies
The results of individual studies included in the main meta- 
analysis can be found in table 1 and within forest plots in figure 2 
(unadjusted) and figure 3 (adjusted). Effect sizes (ORs) ranged 
from 2.46 to 12.31 (unadjusted). All estimates were considered 
to show strong evidence of a positive association between e- cig-
arette use among non- smokers and later smoking in unadjusted 
analyses. Covariates included in the adjusted analyses varied on 
a study- by- study basis. After adjustment, effects in all but three 
studies6 9 18 remained strong. The inclusion of covariates in the 
model attenuated most results (although none were attenuated 
to the null). Effect sizes were strengthened after adjustment in 
four studies.13 15 20 21
synthesis of results
When pooled in a random- effects meta- analysis, e- cigarette use 
in non- smoking young people was associated with a four- and- 
a- half- fold increase in the odds of subsequent smoking (unad-
justed; OR: 4.59, 95% CI: 3.60 to 5.85). Pooling the adjusted 
estimates, the association was still strong but somewhat weaker 
(adjusted; OR: 2.92, 95% CI: 2.30 to 3.71). Heterogeneity 
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Figure 4 Funnel plot to assess the risk of bias across studies.
statistics indicated there was high heterogeneity in both the 
unadjusted (I²=88%) and adjusted (I²=85%) analyses.
Forest plots of the analyses subgrouped by varying exposure 
and outcome levels can be found in the online supplementary 
figures S1- S4. Of the 16 studies included in the unadjusted 
meta- analyses, 13 provided results that explored ever e- ciga-
rette use and ever smoking and 3 studies provided results for 
ever e- cigarette use and current smoking. Three studies explored 
past 30- day e- cigarette use and ever smoking. Further studies 
explored: past 30- day use of e- cigarettes and past 30- day 
smoking (one study), frequency of e- cigarette use (one study) 
and frequency of smoking (one study). Pooled analyses were not 
possible for these subgroups.
Ever e-cigarette use and ever smoking subgrouping
Pooled analyses of studies exploring ever vaping among never 
smokers and subsequent ever smoking resulted in a pooled 
unadjusted OR of 4.17 (95% CI: 3.53 to 6.29). Heterogeneity 
between included studies in this analysis was high (I²=90%). 
The results of the pooled adjusted analysis were similar with 
slightly lower odds (OR: 3.13, 95% CI: 2.35 to 4.16). Hetero-
geneity between included studies was still high in the adjusted 
analysis (I²=84%).
Ever e-cigarette use and current smoking subgrouping
Among never smokers, pooled unadjusted analyses indicated ever 
e- cigarette users had increased odds of subsequently becoming a 
current smoker (OR: 4.35, 95% CI: 2.95 to 6.42) compared 
with never e- cigarette users. Heterogeneity estimates indicated 
low heterogeneity (I²=41%). Adjusted analyses showed similar 
but weakened results when pooled (OR: 2.21, 95% CI: 1.72 to 
2.84). Heterogeneity was indicated as low in the adjusted pooled 
analyses (I²=5%).
Current e-cigarette use and ever smoking subgrouping
Past 30- day use of e- cigarettes among never smokers was asso-
ciated with increased odds of ever subsequently smoking (OR: 
5.64, 95% CI: 3.75 to 8.50) in pooled unadjusted analysis. 
Heterogeneity estimates indicated low heterogeneity (I²=49%). 
The pooled adjusted analysis also indicated increased odds of 
ever subsequently smoking (OR: 2.33, 95% CI: 1.84 to 2.96). 
Heterogeneity estimates also indicated low heterogeneity when 
the adjusted results were pooled (I²=5%).
Stratification by age
When the unadjusted main analyses were stratified by age 
(including versus excluding under the age of 18 years) the pooled 
OR among studies including those under the age of 18 years was 
slightly higher (OR: 4.87, 95% CI: 3.73 to 6.35) than the pooled 
OR of studies excluding those under the age of 18 years (OR: 
3.17, 95% CI: 2.37 to 4.25). Heterogeneity estimates indicated 
that there was low heterogeneity between studies excluding 
those under the age of 18 years (I²=32%) but high heteroge-
neity between studies including those under the age of 18 years 
(I²=88%). Adjusted pooled analyses are reported in the online 
supplementary figures S5 and S6.
Stratification by study quality/risk of bias
Due to limited variation in quality rating of studies using the 
NOS, fair and poor quality studies were pooled and compared 
with good quality studies. The pooled unadjusted OR for studies 
rated as good quality (n=13 studies; OR: 4.29, 95% CI: 3.67 
to 5.01) was lower than the pooled odds ratios for fair/poor 
quality studies (n=3 studies; OR: 5.41, 95% CI: 1.67 to 17.51). 
Heterogeneity measures indicated that high- quality studies were 
less heterogeneous than fair/poor quality studies (I²=60% and 
I²=97%, respectively). Adjusted pooled analyses are shown in 
the online supplementary figures S7 and S8.
Stratification by support for the gateway hypothesis
During the review process, it became apparent that many studies 
did not draw clear conclusions regarding the gateway hypothesis 
or made balanced conclusions. This made it difficult to catego-
rise studies and as such we were unable to stratify based on this 
criterion.
Stratification by location of study
There were only two countries in which more than one included 
study was conducted; 10 studies took place in the USA and 3 
took place in the UK. The pooled estimate for unadjusted odds 
of studies conducted in the USA was 3.95 (95% CI: 3.17 to 
4.92) and in the UK was 5.55 (95% CI: 3.94 to 7.82). Heteroge-
neity for studies conducted was high in the USA (I²=93%) and 
moderate in the UK (I²=52%). The other studies were located in 
the Netherlands, Germany, Canada and Mexico. Pooling these 
results, the odds of subsequent smoking was 4.75 (95% CI: 2.54 
to 8.89) with high heterogeneity between studies (I²=96%). 
Adjusted pooled analyses are shown in the online supplementary 
S9- S11.
Risk of bias across studies
The risk of bias across studies is shown in a funnel plot in 
figure 4. The figure is somewhat asymmetrical and some points 
(25%) lie above the superimposed funnel limits (95% confidence 
region) suggesting that there may be some publication bias and 
indicating there may be heterogeneity (as supported by the I2 
statistics) or selection bias across the included studies.22
DIsCussIOn
Our results indicated that self- reported non- smokers who 
have used e- cigarettes have four- and- a- half- fold higher odds 
of subsequently reporting being smokers than those who have 
not. The pooled adjusted estimate indicated a weaker, although 
still strong, association with nearly three- fold increased odds 
of later smoking. Subgrouping and stratification revealed some 
differences between groups, but all findings indicated a strong 
 o
n
 April 20, 2020 by guest. Protected by copyright.
http://tobaccocontrol.bmj.com/
Tob Control: first published as 10.1136/tobaccocontrol-2019-055433 on 10 M
arch 2020. Downloaded from
 
6 Khouja JN, et al. Tob Control 2020;0:1–8. doi:10.1136/tobaccocontrol-2019-055433
Review
positive association. The main findings were consistent with the 
findings of Soneji and colleagues,5 whereby there was a strong 
positive association between e- cigarette use among non- smokers 
and subsequent smoking and a high degree of heterogeneity 
between studies. Similar to Soneji and colleagues,5 stratification 
by age revealed slightly lower pooled estimates for the odds of 
smoking in studies that excluded those under the age of 18 years 
compared with studies including them. Stratification by location 
indicated stronger associations in the UK compared with the 
USA and other countries. We identified an additional 11 studies 
that were not included in the Soneji meta- analysis. One study 
that was included in the Soneji and colleagues meta- analysis5 was 
not included in this meta- analysis; it was substituted for more 
recent evidence using an overlapping dataset.23 In addition, one 
conference abstract was substituted for the published article.24
Three of the four preselected Bradford- Hill criteria (strength 
of association, temporality and specificity) were commonly 
rated as having been met in the included studies. Despite the 
high heterogeneity statistics, the included study estimates are 
consistently in the same direction and there are plausible causal 
pathways (eg, nicotine addiction, similar hand- to- mouth actions 
for both behaviours). This suggests that the results provide some 
support for a causal relationship between e- cigarette use and 
later smoking. This is in line with the theory that e- cigarettes 
act as a gateway to smoking.3 25 Commonly in the literature, 
the claim is that the gateway effect is attributable to nicotine 
addiction.25 E- cigarettes have historically not delivered nico-
tine as effectively as cigarettes,26 so that e- cigarettes may not be 
adequate to satisfy users who become more heavily addicted to 
nicotine.27 In contrast, the common liability theory proposes that 
people who use multiple drugs (or in this case different delivery 
methods of the same drug) share the same predisposing factors.28 
When considering a causal relationship between e- cigarette use 
and later smoking (eg, the gateway hypothesis), these shared 
factors/confounders (ie, the common liability theory) should 
be taken into account. Due to a lack of consideration of such 
factors in the included studies, we have some reservations about 
inferring a causal relationship. We discuss our reservations below 
with respect to Bradford- Hill criteria for causality, highlighting 
the need for additional research that may help to strengthen the 
evidence for a causal relationship.
The majority of studies included in the meta- analysis satisfied 
the temporality criterion. All studies except one were longitu-
dinal and measured exposure prior to smoking and smoking at 
follow- up; therefore, the observed association between earlier 
e- cigarette use and later smoking is unlikely to be due to reverse 
causality (ie, smoking leading to e- cigarette use). However, 
smoking status is sometimes misreported by young people,29 
meaning that some self- reported non- smokers at baseline may 
in fact have smoked previously. If ever smokers misreport their 
smoking history at baseline, but they accurately report that they 
are ever smokers at follow- up, the association could be biassed 
away from the null. Self- reports were validated in one study30 
using breath carbon monoxide levels; however, with the short 
half- life of breath carbon monoxide (4–6 hours), this measure 
is not suitable to validate self- reports of ever smoking. In future 
research, the use of biomarkers that can identify long- term 
exposure could help researchers to objectively confirm self- 
reported smoking status at baseline. Differential DNA methyla-
tion signals have been observed among smokers compared with 
non- smokers31 32and it is plausible that different signals would 
be observed among e- cigarette users. Eventually, researchers may 
be able to use these methylation signatures to exclude people 
who misreport their behaviour. Consequently, researchers could 
more confidently dismiss reverse causation as an explanation for 
the association.
It is also worth noting that our measure of specificity was rela-
tively liberal. We rated studies as specific if they adjusted for more 
than basic demographic factors. In a recent cross- sectional study, 
accounting for shared risk factors fully explained the relation-
ship between e- cigarette use and current smoking, demonstrating 
the importance of adjusting for potential confounders such as 
alcohol and drug use, peer smoking and risk- taking behaviour.33 
In addition, some potential confounders, like impulsivity, are 
difficult to fully capture via self- report and are often assessed 
relatively crudely. Had we considered only studies adjusting for 
behavioural risk factors (eg, alcohol and marijuana use) to meet 
this criterion, only six studies would have been rated as specific. 
Adjusting for these factors considerably reduced the OR and/or 
widened the CI compared with the unadjusted analysis. As statis-
tical adjustment can never fully remove the risk of confounding, 
other approaches to exploring the potential for a common 
liability (eg, to risk taking) explaining the observed association 
between e- cigarette use and smoking are warranted. One way of 
exploring specificity of this relationship more thoroughly (which 
none of the included studies did) would be the use of negative 
control outcomes (ie, outcomes that have similar confounding 
structures to smoking but for which there is no biologically 
plausible mechanism for e- cigarette use being a causal factor). 
For example, using an e- cigarette is unlikely to cause other risky 
behaviours such as the number of sexual partners a person has; 
if similar associations are seen between e- cigarette use and both 
smoking and number of sexual partners, it would indicate that 
the link may be caused by common underlying factors. Further-
more, exploring the genetic aetiology of e- cigarette use may help 
in understanding whether e- cigarette use and smoking share a 
common liability. If e- cigarette use has a shared genetic aetiology 
with negative control outcomes for which there are no plausible 
pathways through which e- cigarette use would be a causal factor 
(eg, gambling), this would suggest that the association is due 
to the two behaviours sharing a common genetic liability. The 
triangulation of evidence obtained using different methods will 
be critical here.34
To meet the final pre- selected Bradford- Hill criterion, dose–
response, increased e- cigarette use should lead to greater risk 
of later smoking. Despite the most likely causal pathway from 
e- cigarette use to later smoking being via nicotine addiction,3 
only one of the included studies measured and took into account 
the nicotine content of the e- cigarettes used. This study indicated 
that both use of nicotine containing e- cigarettes and (to a lesser 
extent) non- nicotine containing e- cigarettes are strongly associ-
ated with later smoking.13 This suggests that nicotine exposure 
may be one factor in the association between e- cigarette use and 
later smoking, but not the sole mechanism. Unfortunately, the 
study reported analyses based on nicotine versus non- nicotine 
vaping in which these two groups were not mutually exclusive 
(ie, individuals would be in both analysis groups if they tried 
both nicotine containing and nicotine free e- cigarettes). Thus, 
it is unclear whether there is an association between e- cigarette 
use among non- smokers and later smoking when users have 
not been exposed to nicotine. To determine whether there is a 
nicotine dose- response involved in the association, we would 
also need to observe the frequency of e- cigarette use prior to 
smoking. The one study that looked at frequency of use (at four 
levels) indicated that there may be a dose–response to nicotine 
when comparing use just one/two times with use weekly/daily.14 
However, the odds of later smoking did not increase linearly with 
each increased level of frequency of use. However, as nicotine is 
 o
n
 April 20, 2020 by guest. Protected by copyright.
http://tobaccocontrol.bmj.com/
Tob Control: first published as 10.1136/tobaccocontrol-2019-055433 on 10 M
arch 2020. Downloaded from
 
7Khouja JN, et al. Tob Control 2020;0:1–8. doi:10.1136/tobaccocontrol-2019-055433
Review
What this paper adds
 ► There are concerns that e- cigarettes may cause youth 
and young adults who have never smoked before to start 
smoking.
 ► A previous meta- analysis of nine studies has shown that 
there is a positive association between e- cigarette use 
and later smoking (sometimes referred to as the gateway 
hypothesis).
 ► Our meta- analysis of 17 studies indicates e- cigarette use 
among non- smokers is associated with later smoking.
 ► However, the results do not provide strong evidence of a 
gateway effect.
metabolised differently on an individual basis, direct measures of 
nicotine rather than frequency of use may be necessary to deter-
mine whether there is a dose–response. Although nicotine may 
play a causal role in the relationship between e- cigarette use and 
smoking, without further study of any dose–response relation-
ship (including the study of nicotine content and frequency of 
e- cigarette use), we cannot confidently infer causality according 
to Bradford- Hill criteria.
Our heterogeneity statistics of 88% (unadjusted analyses) 
and 85% (adjusted analyses) indicate that our effect esti-
mates should be interpreted with caution. Although there is 
no commonly agreed on strict threshold for heterogeneity, as 
a rough guide, the Cochrane Handbook suggests that I2 statis-
tics of between 75% and 100% represent considerable hetero-
geneity.8 Age contributed to the observed heterogeneity in our 
meta- analysis—the association was stronger in studies including 
those under the age of 18 years than studies excluding them. In 
adolescence, risk- taking is common35 and decision making for 
health- risk behaviours is influenced by peers, societal influences 
and parental monitoring, but these factors are less influential to 
adults.36 Such factors are likely to be confounders of the associ-
ation between e- cigarette use and later smoking, particularly in 
studies of those under the age of 18 years and should be included 
as covariates where possible. The results stratified by location 
also suggested there may be societal influences on the associa-
tion; the association was stronger among studies based in the UK 
than those based in the USA. This suggests that country- specific 
societal factors such as legislation, taxation, social norms and 
public opinion may be confounding this association such that 
study results may not be generalisable to other countries.
In conclusion, there is a strong consistent association in obser-
vational studies between e- cigarette use among non- smokers 
and later smoking. However, findings from published studies do 
not provide clear evidence that this is explained by a gateway 
effect rather than shared common causes of both e- cigarette use 
and smoking. This emphasises the need for a scientific forum to 
discuss the evidence to date and directions for future research. 
Future research should consider including relevant potential 
confounders, such as better measures of impulsivity and other 
measures of propensity to risk taking, and objective measures 
of smoking status in order to better explore the potential role 
of e- cigarettes as a gateway to smoking. Studies that explore 
the genetic underpinnings of these behaviours and use negative 
control outcomes may also help improve our understanding of 
the association between e- cigarette use and later smoking. A 
scoping review, including qualitative evidence, could provide 
a clearer understanding of the why e- cigarette use is associ-
ated with later smoking. Importantly, any recommendations 
regarding e- cigarette regulations to limit the burden of future 
smoking must consider the potential beneficial impact of e- ciga-
rette use on smoking cessation.37
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